News

The trial, which will be conducted in healthy male volunteers, is a combined single and multiple ascending dose safety, tolerability and pharmacokinetic trial. The company expects to evaluate

PSI-938 is an oral guanosine nucleotide analog polymerase inhibitor of HCV. Earlier in Nuclear study , PSI-938 showed potent antiviral activity and was generally safe and well tolerated,

In the study, the patients were optimized on an endothelin receptor antagonist, a phosphodiesterase-5 inhibitor, or both. The trial involved around 310 patients. United Therapeutics’ president and chief

The acquisition will strengthen Aventis Pharma’s business in India and allow the company to create a consumer healthcare and wellness platform in the country. Universal Medicare is a

Ajanta’s Paithan manufacturing plant has also got the US Food and Drug Administration (FDA) approval earlier. Additionally, Ajanta’s Paithan facility also holds the WHO Pre-qualification approval from WHO

As part of this acquisition, ISP will be merged into Ashland Aqualon Functional Ingredients commercial unit and the combined unit will be known as Ashland Specialty Ingredients. Ashland

Hydrocortisone-D, which uses the company’s proprietary drug delivery technology NexACT, combines hydrocortisone with DDAIP. The active ingredient in the cleared OTC drug, hydrocortisone, is an already approved anti-itch

Multikine is currently being developed as a treatment for head and neck cancer. Currently, CEL-SCI has existing licensing deals for Multikine with Teva Pharmaceuticals, Orient Europharma and Byron

Merck Animal Health provides veterinarians, farmers, pet owners and governments a range of veterinary pharmaceuticals, vaccines and health management solutions. DeLuca worked as the chief financial officer of